Toray Industries, Inc. - 3402.T

3402.T Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
3402.T	-1.4	-1.2	1.3	22.9	26.3	39.8	35.8	32.2	5.0	154.8
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare 3402.T with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	3402.T
name	Toray Industries, Inc.
price	1009
changes percentage	-1.4167
change	-14.5
day low	993.5
day high	1009
year high	1036
year low	633
market cap	1616598621090
price avg 50	973.304
price avg 200	819.645
exchange	JPX
volume	5590500
avg volume	6348761
open	1000
previous close	1023.5
eps	30.23
pe	33.38
earnings announcement	2025-02-12T03:30:00.000+0000
shares outstanding	1602179010
timestamp	2025-01-17 06:45:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 63.7%

Overall Quarterly Financial Health: 61.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	2464596000000	2489330000000	-0.99
gross profit	443523000000	420835000000	5.39
gross profit ratio	0.18	0.17	6.45
research and development expenses	69486000000	68900000000	0.85
operating expenses	346344000000	311834000000	11.07
interest income	12149000000	8484000000	43.20
interest expense	19083000000	13013000000	46.65
ebitda	207844000000	218998000000	-5.09
ebitdaratio	0.08	0.1	-16.45
operating income	97179000000	109001000000	-10.85
operating income ratio	0.04	0.04	-9.95
net income	21897000000	72823000000	-69.93
net income ratio	0.01	0.03	-69.63
eps	13.67	45.49	-69.95

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 2,464,596 million in 2023 from 2,489,330 million in 2022 representing a change of -0.99%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 346,344 million in 2023 from 311,834 million in 2022 representing a change of 11.07%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 207,844 million in 2023 from 218,998 million in 2022 representing a change of -5.09%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 21,897 million in 2023 from 72,823 million in 2022 representing a change of -69.93%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 13.67 in 2023 from 13.67 in 2022 representing a change of -69.95%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 443,523 million in 2023 from 420,835 million in 2022 representing a change of 5.39%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 69,486 million in 2023 from 68,900 million in 2022 representing a change of 0.85%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 97,179 million in 2023 from 109,001 million in 2022 representing a change of -10.85%. The increase in operating income indicates better operational performance and increased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q1	2023Q4	Q/Q change %
0000000000
revenue	637726000000	635188000000	0.40
gross profit	126548000000	116034000000	9.06
gross profit ratio	0.2	0.18	8.63
research and development expenses	0	19286000000	-100.00
operating expenses	89956000000	91765000000	-1.97
interest income	5190000000	1704000000	204.58
interest expense	4741000000	4642000000	2.13
ebitda	70814000000	20359000000	247.83
ebitdaratio	0.11	0.09	24.52
operating income	36592000000	24269000000	50.78
operating income ratio	0.06	0.04	50.18
net income	26859000000	-23762000000	213.03
net income ratio	0.04	-0.04	212.58
eps	16.77	-14.84	213.01

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 637,726 million in 2024Q1 from 635,188 million in 2023Q4 representing a change of 0.4%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 126,548 million in 2024Q1 from 116,034 million in 2023Q4 representing a change of 9.06%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 89,956 million in 2024Q1 from 91,765 million in 2023Q4 representing a change of -1.97%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 70,814 million in 2024Q1 from 20,359 million in 2023Q4 representing a change of 247.83%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 36,592 million in 2024Q1 from 24,269 million in 2023Q4 representing a change of 50.78%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 26,859 million in 2024Q1 from -23,762 million in 2023Q4 representing a change of 213.03%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 16.77 in 2024Q1 from 16.77 in 2023Q4 representing a change of 213.01%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q1 from 19,286 million in 2023Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	3466518000000	3194041000000	8.53
total liabilities	1620156000000	1558231000000	3.97
total equity	1846362000000	1635810000000	12.87
cash and cash equivalents	235887000000	223995000000	5.31
short term investments	0	30692000000	-100.00
long term investments	507243000000	503475000000	0.75
total current assets	1522640000000	1429279000000	6.53
total non current assets	1943878000000	1764762000000	10.15
total current liabilities	865734000000	826211000000	4.78
total non current liabilities	754422000000	732020000000	3.06
common stock	147873000000	147873000000	0.00
retained earnings	1068364000000	1037120000000	3.01
total debt	949684000000	950093000000	-0.04

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3,466,518 million in 2023 from 3,194,041 million in 2022 representing a change of 8.53%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,846,362 million in 2023 from 1,635,810 million in 2022 representing a change of 12.87%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 235,887 million in 2023 from 223,995 million in 2022 representing a change of 5.31%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 1,522,640 million in 2023 from 1,429,279 million in 2022 representing a change of 6.53%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 1,068,364 million in 2023 from 1,037,120 million in 2022 representing a change of 3.01%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 949,684 million in 2023 from 950,093 million in 2022 representing a change of -0.04%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,620,156 million in 2023 from 1,558,231 million in 2022 representing a change of 3.97%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 30,692 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 865,734 million in 2023 from 826,211 million in 2022 representing a change of 4.78%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q1	2023Q4	Q/Q change %
0000000000
total assets	3596022000000	3466518000000	3.74
total liabilities	1650442000000	1620156000000	1.87
total equity	1945580000000	1846362000000	5.37
cash and cash equivalents	247967000000	235887000000	5.12
short term investments	87705000000	12973000000	576.06
long term investments	530209000000	507243000000	4.53
total current assets	1569906000000	1522640000000	3.10
total non current assets	2026116000000	1943878000000	4.23
total current liabilities	873087000000	865734000000	0.85
total non current liabilities	777355000000	754422000000	3.04
common stock	147873000000	147873000000	0.00
retained earnings	1081513000000	1068364000000	1.23
total debt	970800000000	949684000000	2.22

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3,596,022 million in 2024Q1 from 3,466,518 million in 2023Q4 representing a change of 3.74%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,945,580 million in 2024Q1 from 1,846,362 million in 2023Q4 representing a change of 5.37%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 247,967 million in 2024Q1 from 235,887 million in 2023Q4 representing a change of 5.12%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 87,705 million in 2024Q1 from 12,973 million in 2023Q4 representing a change of 576.06%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 1,569,906 million in 2024Q1 from 1,522,640 million in 2023Q4 representing a change of 3.1%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 1,081,513 million in 2024Q1 from 1,068,364 million in 2023Q4 representing a change of 1.23%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,650,442 million in 2024Q1 from 1,620,156 million in 2023Q4 representing a change of 1.87%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 873,087 million in 2024Q1 from 865,734 million in 2023Q4 representing a change of 0.85%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 970,800 million in 2024Q1 from 949,684 million in 2023Q4 representing a change of 2.22%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	11892000000	-6360000000	286.98
operating cash flow	185680000000	145213000000	27.87
free cash flow	51550000000	42997000000	19.89
capital expenditure	-134130000000	-102216000000	-31.22
depreciation and amortization	129194000000	126375000000	2.23
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	-3104000000	-10735000000	71.09
inventory	22860000000	-33608000000	168.02
acquisitions net	-6456000000	3628000000	-277.95
investments in property plant and equipment	-134130000000	-102216000000	-31.22
net cash used for investing activites	-120997000000	-102724000000	-17.79
debt repayment	-53353000000	-59101000000	9.73
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-28828000000	-27225000000	-5.89
net cash used provided by financing activities	-70370000000	-57378000000	-22.64
cash at end of period	235887000000	223995000000	5.31
accounts receivables	-51380000000	3405000000	-1608.96
cash at beginning of period	223995000000	230355000000	-2.76

Overall Score of Annual Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 11,892 million in 2023 from -6,360 million in 2022 representing a change of 286.98%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 185,680 million in 2023 from 145,213 million in 2022 representing a change of 27.87%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 51,550 million in 2023 from 42,997 million in 2022 representing a change of 19.89%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -134,130 million in 2023 from -102,216 million in 2022 representing a change of -31.22%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 3,104 million in 2023 from 10,735 million in 2022 representing a change of 71.09%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -51,380 million in 2023 from 3,405 million in 2022 representing a change of -1608.96%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Dividends Paid: Dividends Paid decreased to -28,828 million in 2023 from -27,225 million in 2022 representing a change of -5.89%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q1	2023Q4	Q/Q change %
0000000000
operating cash flow	57078000000	79435000000	-28.15
free cash flow	17554000000	37499000000	-53.19
capital expenditure	-39524000000	-41936000000	5.75
depreciation and amortization	32739000000	32373000000	1.13
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	18699000000	-18302000000	202.17
accounts payables	628000000	-1013000000	161.99
inventory	-15728000000	33131000000	-147.47
acquisitions net	0	146000000	-100.00
investments in property plant and equipment	-39524000000	-41936000000	5.75
net cash used for investing activites	-36504000000	-34081000000	-7.11
debt repayment	-10798000000	-73276000000	85.26
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-13848000000	-69000000	-19969.57
net cash used provided by financing activities	-20746000000	-47624000000	56.44
net change in cash	12080000000	6495000000	85.99
cash at end of period	247967000000	235887000000	5.12
cash at beginning of period	235887000000	229392000000	2.83

Overall Score of Quarterly Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 12,080 million in 2024Q1 from 6,495 million in 2023Q4 representing a change of 85.99%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables decreased to 628 million in 2024Q1 from 1,013 million in 2023Q4 representing a change of 161.99%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 57,078 million in 2024Q1 from 79,435 million in 2023Q4 representing a change of -28.15%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 17,554 million in 2024Q1 from 37,499 million in 2023Q4 representing a change of -53.19%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -39,524 million in 2024Q1 from -41,936 million in 2023Q4 representing a change of 5.75%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 18,699 in 2024Q1 from -18,302 million in 2023Q4 representing a change of 202.17%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -13,848 million in 2024Q1 from -69 million in 2023Q4 representing a change of -19969.57%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q1 2024 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	1538.89	1554.9	-1.03
net income per share	13.67	45.49	-69.94
operating cash flow per share	115.94	90.7	27.82
free cash flow per share	32.19	26.86	19.85
cash per share	147.29	159.08	-7.42
book value per share	1152.87	1021.77	12.83
tangible book value per share	1033.44	909.32	13.65
shareholders equity per share	1083.98	958.82	13.05
interest debt per share	604.9	601.58	0.55
market cap	1144940946000	1210966900400	-5.45
enterprise value	1858737946000	1937064900400	-4.04
pe ratio	52.29	16.63	214.44
price to sales ratio	0.46	0.49	-4.50
pocfratio	6.17	8.34	-26.06
pfcf ratio	22.21	28.16	-21.14
pb ratio	0.66	0.79	-16.40
ptb ratio	0.66	0.79	-16.40
ev to sales	0.75	0.78	-3.08
enterprise value over ebitda	8.94	8.85	1.11
ev to operating cash flow	10.01	13.34	-24.96
ev to free cash flow	36.06	45.05	-19.96
earnings yield	0.02	0.06	-68.20
free cash flow yield	0.05	0.04	26.81
debt to equity	0.55	0.62	-11.62
debt to assets	0.27	0.3	-7.90
net debt to ebitda	3.43	3.32	3.58
current ratio	1.76	1.73	1.67
interest coverage	5.09	8.38	-39.20
income quality	8.48	1.3	553.26
dividend yield	0.03	0.02	11.99
payout ratio	1.32	0.37	252.15
sales general and administrative to revenue	0.14	0.13	5.72
research and ddevelopement to revenue	0.03	0.03	1.86
intangibles to total assets	0.06	0.06	-2.11
capex to operating cash flow	0.72	0.7	2.62
capex to revenue	0.05	0.04	32.54
capex to depreciation	1.04	0.81	28.36
stock based compensation to revenue	0	0	NaN
graham number	577.46	990.61	-41.71
roic	0.02	0.03	-41.91
return on tangible assets	0.01	0.02	-72.33
graham net net	-389.37	-376.75	-3.35
working capital	656906000000	603068000000	8.93
tangible asset value	1655097000000	1455784000000	13.69
net current asset value	-97516000000	-128952000000	24.38
invested capital	1979772000000	1840086000000	7.59
average receivables	622857000000	581490500000	7.11
average payables	332198000000	325797000000	1.96
average inventory	526778500000	495457000000	6.32
days sales outstanding	97.68	85.94	13.67
days payables outstanding	61.45	57.2	7.43
days of inventory on hand	96.07	92.04	4.38
receivables turnover	3.74	4.25	-12.02
payables turnover	5.94	6.38	-6.92
inventory turnover	3.8	3.97	-4.20
roe	0.01	0.05	-73.41
capex per share	83.75	63.85	31.17

• Negative

  ROE: Return on Equity (ROE) decreased to 0.01 on 2024-03-31 from 0.05 on 2023-03-31, representing a change of -73.41%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 52.29 on 2024-03-31 from 16.63 on 2023-03-31, representing a change of 214.44%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.76 on 2024-03-31 from 1.73 on 2023-03-31, representing a change of 1.67%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.55 on 2024-03-31 from 0.62 on 2023-03-31, representing a change of -11.62%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q1	2024-03-31 Q4	Q/Q change %
3402.T
calendar year	2024	2023	NaN
revenue per share	398.08	396.59	0.38
net income per share	16.77	-14.84	213.01
operating cash flow per share	35.63	49.6	-28.16
free cash flow per share	10.96	23.41	-53.20
cash per share	209.53	155.38	34.85
book value per share	1214.47	1152.79	5.35
tangible book value per share	1088.02	1033.37	5.29
shareholders equity per share	1143.29	1083.91	5.48
interest debt per share	608.95	595.84	2.20
market cap	1220725011936	1145014153904.7	6.61
enterprise value	1943558011936	1858811153904.7	4.56
pe ratio	11.36	-12.05	194.32
price to sales ratio	1.91	1.8	6.19
pocfratio	21.39	14.41	48.37
pfcf ratio	69.54	30.53	127.75
pb ratio	0.67	0.66	1.05
ptb ratio	0.67	0.66	1.05
ev to sales	3.05	2.93	4.14
enterprise value over ebitda	27.45	91.3	-69.94
ev to operating cash flow	34.05	23.4	45.51
ev to free cash flow	110.72	49.57	123.36
earnings yield	0.02	-0.02	206.02
free cash flow yield	0.01	0.03	-56.09
debt to equity	0.53	0.55	-3.11
debt to assets	0.27	0.27	-1.46
net debt to ebitda	10.21	35.06	-70.89
current ratio	1.8	1.76	2.24
interest coverage	7.72	5.23	47.63
income quality	2.13	-3.34	163.57
dividend yield	0.01	0.0	18724.83
payout ratio	0.52	-0.0	17855.43
sales general and administrative to revenue	0	0.14	-100.00
research and ddevelopement to revenue	0	0.03	-100.00
intangibles to total assets	0.06	0.06	2.10
capex to operating cash flow	0.69	0.53	31.16
capex to revenue	0.06	0.07	-6.13
capex to depreciation	1.21	1.3	-6.81
stock based compensation to revenue	0	0	NaN
graham number	656.72	601.51	9.18
roic	0.01	0.01	-23.66
return on tangible assets	0.01	-0.01	209.10
graham net net	-338.64	-381.24	11.18
working capital	696819000000	656906000000	6.08
tangible asset value	1743004000000	1655097000000	5.31
net current asset value	-80536000000	-97516000000	17.41
invested capital	2076937000000	1979772000000	4.91
average receivables	656411000000	641855500000	2.27
average payables	339904000000	333630000000	1.88
average inventory	548333500000	541678000000	1.23
days sales outstanding	92.19	93.46	-1.36
days payables outstanding	59.78	58.99	1.35
days of inventory on hand	99.42	92.22	7.81
receivables turnover	0.98	0.96	1.38
payables turnover	1.51	1.53	-1.33
inventory turnover	0.91	0.98	-7.25
roe	0.01	-0.01	207.14
capex per share	24.67	26.18	-5.77

• Negative

  ROE: Return on Equity (ROE) increased to 0.01 on 2024-06-30 Q1 from -0.01 on 2024-03-31 Q4, representing a change of 207.14%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 11.36 on 2024-06-30 Q1 from -12.05 on 2024-03-31 Q4, representing a change of 194.32%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.80 on 2024-06-30 Q1 from 1.76 on 2024-03-31 Q4, representing a change of 2.24%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.53 on 2024-06-30 Q1 from 0.55 on 2024-03-31 Q4, representing a change of -3.11%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 1136.29 which is higher than current price 1009, indicates the company may be undervalued.